Evofem Biosciences Inc (EVFM)
0.0140
0.00 (0.00%)
USD |
OTCM |
Nov 05, 14:21
Evofem Biosciences Profit Margin (Quarterly): 32.48% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 32.48% |
| March 31, 2024 | -133.5% |
| December 31, 2023 | -43.69% |
| September 30, 2023 | |
| June 30, 2023 | -348.2% |
| March 31, 2023 | -40.52% |
| December 31, 2022 | -4.61K% |
| September 30, 2022 |
| Date | Value |
|---|---|
| June 30, 2022 | -2.09K% |
| March 31, 2022 | -750.1% |
| December 31, 2021 | -1.44K% |
| September 30, 2021 | -4.33K% |
| June 30, 2021 | -1.80K% |
| March 31, 2021 | -4.18K% |
| December 31, 2020 | -24.17K% |
| September 30, 2020 | -10.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-24.17K%
Minimum
Dec 2020
32.48%
Maximum
Jun 2024
-3.90K%
Average
-1.62K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 552.2% |
| Gross Profit Margin (Quarterly) | 81.51% |
| Operating Margin (Quarterly) | -33.39% |
| Return on Net Operating Assets | 614.8% |